Use of Eltrombopag in Improving Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Use of Eltrombopag in Improving Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation ; volume:11 ; number:1 ; year:2018 ; pages:191-195
Case reports in oncology ; 11, Heft 1 (2018), 191-195
- Urheber
-
Master, Samip
Dwary, Ashish
Mansour, Richard
Mills, Glenn M.
Koshy, Nebu
- DOI
-
10.1159/000487229
- URN
-
urn:nbn:de:101:1-201805242291
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Master, Samip
- Dwary, Ashish
- Mansour, Richard
- Mills, Glenn M.
- Koshy, Nebu
Ähnliche Objekte (12)
Successful treatment of secondary poor graft function post allogeneic hematopoietic stem cell transplantation with eltrombopag
Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the EBMT, ASTCT, CIBMTR, and APBMT
Graft conditioning with fluticasone propionate reduces graft‐versus‐host disease upon allogeneic hematopoietic cell transplantation in mice
Correction: Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the EBMT, ASTCT, CIBMTR, and APBMT
Aberrant T cell responses in the bone marrow microenvironment of patients with poor graft function after allogeneic hematopoietic stem cell transplantation
Intestinal dysbiosis and allogeneic hematopoietic progenitor cell transplantation
Dermoscopy of Cutaneous Graft-Versus-Host-Disease in Patients After Allogeneic Hematopoietic Stem Cell Transplantation
Pathological angiogenesis and endothelial dysfunction in Graft-versus-Host Disease after allogeneic hematopoietic stem cell transplantation
Management of dyslipidemia after allogeneic hematopoietic stem cell transplantation
Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation
Role of allogeneic hematopoietic cell transplantation in VEXAS syndrome
Impact of graft invariant natural killer T cells on early cytomegalovirus reactivation following allogeneic hematopoietic cell transplantation
Successful treatment of secondary poor graft function post allogeneic hematopoietic stem cell transplantation with eltrombopag
Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the EBMT, ASTCT, CIBMTR, and APBMT
Graft conditioning with fluticasone propionate reduces graft‐versus‐host disease upon allogeneic hematopoietic cell transplantation in mice
Correction: Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the EBMT, ASTCT, CIBMTR, and APBMT
Aberrant T cell responses in the bone marrow microenvironment of patients with poor graft function after allogeneic hematopoietic stem cell transplantation
Intestinal dysbiosis and allogeneic hematopoietic progenitor cell transplantation
Dermoscopy of Cutaneous Graft-Versus-Host-Disease in Patients After Allogeneic Hematopoietic Stem Cell Transplantation
Pathological angiogenesis and endothelial dysfunction in Graft-versus-Host Disease after allogeneic hematopoietic stem cell transplantation
Management of dyslipidemia after allogeneic hematopoietic stem cell transplantation
Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation
Role of allogeneic hematopoietic cell transplantation in VEXAS syndrome
Impact of graft invariant natural killer T cells on early cytomegalovirus reactivation following allogeneic hematopoietic cell transplantation
Successful treatment of secondary poor graft function post allogeneic hematopoietic stem cell transplantation with eltrombopag
Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the EBMT, ASTCT, CIBMTR, and APBMT
Graft conditioning with fluticasone propionate reduces graft‐versus‐host disease upon allogeneic hematopoietic cell transplantation in mice
Correction: Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the EBMT, ASTCT, CIBMTR, and APBMT
Aberrant T cell responses in the bone marrow microenvironment of patients with poor graft function after allogeneic hematopoietic stem cell transplantation
Intestinal dysbiosis and allogeneic hematopoietic progenitor cell transplantation
Dermoscopy of Cutaneous Graft-Versus-Host-Disease in Patients After Allogeneic Hematopoietic Stem Cell Transplantation
Pathological angiogenesis and endothelial dysfunction in Graft-versus-Host Disease after allogeneic hematopoietic stem cell transplantation
Management of dyslipidemia after allogeneic hematopoietic stem cell transplantation
Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation
Role of allogeneic hematopoietic cell transplantation in VEXAS syndrome